Veracyte, Inc. VCYT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 151.75M | 150.32M | 139.07M | 140.64M | 131.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.75M | 150.32M | 139.07M | 140.64M | 131.87M |
| Cost of Revenue | 37.68M | 35.39M | 35.21M | 45.35M | 34.81M |
| Gross Profit | 114.08M | 114.93M | 103.87M | 95.28M | 97.07M |
| SG&A Expenses | 59.96M | 59.35M | 50.84M | 46.49M | 54.81M |
| Depreciation & Amortization | 3.69M | 3.16M | 3.29M | 3.33M | 3.33M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.49M | 127.34M | 116.43M | 116.02M | 108.93M |
| Operating Income | 18.27M | 22.98M | 22.65M | 24.61M | 22.95M |
| Income Before Tax | 21.12M | 26.52M | 29.97M | 40.63M | 18.89M |
| Income Tax Expenses | -10.38M | 1.03M | 1.27M | -515.00K | -248.00K |
| Earnings from Continuing Operations | 31.50M | 25.49M | 28.71M | 41.15M | 19.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.50M | 25.49M | 28.71M | 41.15M | 19.14M |
| EBIT | 18.27M | 22.98M | 22.65M | 24.61M | 22.95M |
| EBITDA | 24.25M | 27.82M | 28.08M | 29.91M | 28.21M |
| EPS Basic | 0.39 | 0.32 | 0.36 | 0.52 | 0.24 |
| Normalized Basic EPS | 0.18 | 0.21 | 0.24 | 0.22 | 0.20 |
| EPS Diluted | 0.38 | 0.31 | 0.35 | 0.50 | 0.24 |
| Normalized Diluted EPS | 0.17 | 0.20 | 0.23 | 0.22 | 0.20 |
| Average Basic Shares Outstanding | 80.50M | 79.97M | 79.54M | 79.18M | 78.73M |
| Average Diluted Shares Outstanding | 82.78M | 82.06M | 81.31M | 81.39M | 79.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |